oncology
Cancer care

Extended thromboprophylaxis does not reduce VTE in hospitalised cancer patients

Extended thromboprophylaxis in hospitalised patients with cancer does not reduced the rate of venous thromboembolic (VTE) events and is associated with increased risk of haemorrhage, a systematic review has found. While the use of extended (28-42 days) thromboprophylaxis after hospitalisation has previously been shown to have benefit over standard-duration (14 days) thromboprophylaxis, this was not ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic